| Jalpa A. Doshi PhD, Assistant Professor of Medicine, General Internal Medicine, Director, Economic Evaluations Unit, Center for Evidence-Based Practice, Director, Value-Based Insurance Design Initiatives, Center for Health Incentives, University of Pennsylvania, Philadelphia, PA, USA
Bonnie Handke RN, Director, Health Policy and Planning, Medtronic, Inc, Neuromodulation, Shoreview, MN, USA
Jennifer Stephens PharmD,
Clinical Director& Partner, Pharmerit North America LLC, Bethesda, MD, USA
|
Gisselle Gallego PhD, Research Fellow, Centre for Health Economics Research and
Evaluation (CHERE) University of Sydney, Australia
Wim Goettsch PhD, Consultant Pharmacoeconomics Dutch Health Insurance Board, Diemen, Netherland
Seema Haider MSc, Director, Pfizer Inc, Global HE/OR,Groton, CT, USA
Franz Hessel MD, MPH, Senior Manager, Sanofi-Aventis, Managed Markets / HEOR, Berlin, Germany
Tove Holm-Larsen MSc, University of Denmark, Denmark
Deborah Lubeck PhD, Vice President Icon Clinical Research, Half Moon Bay, CA, USA
John O'Donnell PhD, Regional Director, Astra-Zeneca, New York, NY, USA
Dan Ollendorf MPH, Chief Review Officer, Institute for Clinical and Economic Review, Boston, MA, USA
Carlos Gouveia Pinto PhD, Associate Professor of Health Economics, Technical
University of Lisbon, Lisbon, Portugal |